Physician Wealth Advisors’s Beta Bionics BBNX Stock Holding History

Physician Wealth Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13K	Buy	+72	New	+$856	﹤0.01%	1785

Other funds holding BBNX

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Evanson Financial Mclean, Virginia $2.04B AUM

Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Physician Wealth Advisors's BBNX Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Beta Bionics (BBNX) in Q2 2026: 72 shares worth $1.13K. The stake represents ﹤0.01% of the portfolio and ranks #1785 among its holdings.

14 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

Physician Wealth Advisors held 72 shares of Beta Bionics worth $1.13K as of Q2 2026.
Beta Bionics was a new Physician Wealth Advisors position in Q2 2026.
Beta Bionics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1785 holding.
14 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.